IVRO (Invitro International) Degree of Operating Leverage : 4.25 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Invitro International Degree of Operating Leverage?

Invitro International IVRO -1.27% Degree of Operating Leverage is 4.25 as of Jun. 2026. The stock has 1 warning sign investors should review. Among 199 Medical Diagnostics & Research companies, Invitro International ranks worse than 77.89% on this metric.

Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. Invitro International's Degree of Operating Leverage for the quarter that ended in Jun. 2026 was 4.25. The higher Degree of Operating Leverage, the higher operating risk the company will take.

The industry rank for Invitro International's Degree of Operating Leverage or its related term are showing as below:

IVRO's Degree of Operating Leverage is ranked worse than
77.89% of 199 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.6 vs IVRO: 4.25

Invitro International  (OTCPK:IVRO) Degree of Operating Leverage Explanation

Degree of Operating Leverage (DOL) is a leverage ratio that measures the sensitivity of a company’s operting income, also referred to as Earnings Before Interest and Taxes (EBIT), to fluctuations in its Revenue. DOL is a method used to quantify a company’s operating risk. This risk is related to the company's structure of variable costs and fixed costs. Since the fixed costs do not allow the company to adjust the operating costs, the operating risk rises with a higher fixed-to-variable costs proportion.

A high Degree of Operating Leverage indicates that the company’s fixed costs exceed its variable costs. By increasing the sales, the company can earn more profits. In addition, the company must be able to maintain relatively high sales to cover all fixed costs.

Be Aware

The use of operating leverage varies across different industries and business sectors, and the application of Degree of Operating Leverage (DOL) should be adjusted accordingly.


Invitro International Degree of Operating Leverage Related Terms


Invitro International Degree of Operating Leverage Historical Data

* Premium members only.

The historical data trend for Invitro International's Degree of Operating Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invitro International Degree of Operating Leverage Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96 Sep24 Sep25
Degree of Operating Leverage
Get a 7-Day Free Trial Premium Member Only -4.63 0.90 14.01 0.00 2.53

Invitro International Quarterly Data
Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Degree of Operating Leverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.04 2.53 1.49 -148.77 4.25

IVRO vs IDTA, FUNI, BIAF: Degree of Operating Leverage Comparison

For the Diagnostics & Research subindustry, Invitro International's Degree of Operating Leverage, along with its competitors' market caps and Degree of Operating Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invitro International Degree of Operating Leverage vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's Degree of Operating Leverage distribution charts can be found below:

* The bar in red indicates where Invitro International's Degree of Operating Leverage falls into.



Invitro International Degree of Operating Leverage Calculation

Invitro International's Degree of Operating Leverage for the quarter that ended in Jun. 2026 is calculated as:

Degree of Operating Leverage=% Change in EBIT**/% Change in Revenue
=( 0.035 (Jun. 2026) / 0.085 (Jun. 2025) - 1 )/( 0.772 (Jun. 2026) / 0.896 (Jun. 2025) - 1 )
=-0.5882/-0.1384
=4.25***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EBIT and Revenue was used to calculate Degree of Operating Leverage.
*** Please be aware that the Degree of Operating Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

What does a Degree of Operating Leverage of 4.25 mean?
Invitro International (IVRO) has a Degree of Operating Leverage of 4.25 as of Jun. 2026. Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. View historical data for Invitro International and its competitors. According to the industry distribution chart, Invitro International ranks #155 out of 199 companies in the Medical Diagnostics & Research industry, placing it in the top 77.9%.
Is Invitro International's Degree of Operating Leverage too high?
Invitro International's current Degree of Operating Leverage is 4.25. The Medical Diagnostics & Research industry median Degree of Operating Leverage is 0.60. Invitro International's value of 4.25 is 608.3% above this industry median. Based on the distribution chart, Invitro International ranks #155 out of 199 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Invitro International's Degree of Operating Leverage compare to IDTA and FUNI?
According to the Medical Diagnostics & Research industry distribution chart, Invitro International ranks #155 out of 199 companies for Degree of Operating Leverage. This places Invitro International in the lower half of its industry. The industry median Degree of Operating Leverage is 0.60. Invitro International's value of 4.25 is 608.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Degree of Operating Leverage for a Medical Diagnostics & Research company?
The median Degree of Operating Leverage among Medical Diagnostics & Research companies is 0.60, based on 199 companies in the industry. Companies in the top quartile (top 25%) have a Degree of Operating Leverage significantly above this median, while those in the bottom quartile fall well below. However, Degree of Operating Leverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Invitro International's current Degree of Operating Leverage of 4.25 is 608.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Degree of Operating Leverage mean?
A high Degree of Operating Leverage can signal that a stock is expensive relative to its fundamentals. Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. View historical data for Invitro International and its competitors. For the Medical Diagnostics & Research industry, the median Degree of Operating Leverage is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Invitro International's current Degree of Operating Leverage is 4.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invitro International stock overvalued right now?
Based on GuruFocus' analysis, Invitro International (IVRO) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.06, compared to a current price of $0.08 — trading 30% above its estimated fair value. The current Degree of Operating Leverage is 4.25 and 608.3% above the Medical Diagnostics & Research industry median of 0.60. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Degree of Operating Leverage calculated?
Degree of Operating Leverage is calculated from a company's financial statements. For Invitro International (IVRO), the current Degree of Operating Leverage is 4.25 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Invitro International Business Description

Address 330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.